Bladder filling in patients undergoing prostate radiotherapy on the MR-linac

被引：1
|
作者：
Smith, G. Adair [1 ]
Herbert, T. [1 ]
Lawes, R. [1 ]
Creasey, H. [1 ]
Dunlop, A. [2 ]
Mitchell, A. [2 ]
Pathmanathan, A. [1 ]
Bower, L. [3 ]
Hanson, I. [2 ]
McQuaid, D. [2 ]
Huddart, R. [1 ]
Oelfke, U. [2 ]
Nill, S. [2 ]
Tree, A. [1 ]
McNair, H. [1 ]
机构：
[1] Royal Marsden NHS Fdn Trust, Radiotherapy, Sutton, Surrey, England
[2] Inst Canc Res, Med Phys, Sutton, Surrey, England
[3] Inst Canc Res, Radiotherapy & Imaging, Sutton, Surrey, England
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷
关键词：
D O I：
10.1016/S0167-8140(19)32593-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-2173
引用
收藏
页码：S1200 / S1201
页数：2
相关论文
共 50 条
  • [31] Practice- based Training Strategy for Therapist-Driven Prostate MR-Linac Adaptive Radiotherapy
    Li, W.
    Lindsay, P.
    Padayachee, J.
    Navarro, I.
    Winter, J.
    Dang, J.
    Raman, S.
    Kong, V.
    Berlin, A.
    Catton, C.
    Glicksman, R.
    Malkov, V.
    Kataki, K.
    Chung, P.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S108 - S109
  • [32] Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapy
    Li, Winnie
    Padayachee, Jerusha
    Navarro, Inmaculada
    Winter, Jeff
    Dang, Jennifer
    Raman, Srinivas
    Kong, Vickie
    Berlin, Alejandro
    Catton, Charles
    Glicksman, Rachel
    Malkov, Victor
    McPartlin, Andrew
    Kataki, Kaushik
    Lindsay, Patricia
    Chung, Peter
    TECHNICAL INNOVATIONS & PATIENT SUPPORT IN RADIATION ONCOLOGY, 2023, 27
  • [33] Skin markers are no longer a necessity in prostate MR-Linac treatments
    Rutgers, R.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S391 - S392
  • [34] Two-fraction prostate radiotherapy using high field MR-linac: technique and initial experience
    Mitchell, R. A.
    Diamantopoulos, S.
    Dunlop, A.
    Alexander, S.
    Goodwin, E.
    Herbert, T.
    Jones, S.
    Mohajer, J.
    Nill, S.
    Smith, G. A.
    Westley, R.
    Oelfke, U.
    Tree, A.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1460 - S1461
  • [35] Opportunities and challenges in the adoption and implementation of MR-Linac for prostate cancer
    Hehakaya, C.
    Van der Voort van Zyp, J.
    Lagendijk, J.
    Grobbee, D.
    Verkooijen, H.
    Ellen, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S672 - S672
  • [36] Evaluation of Unity 1.5 T MR-linac plan quality in patients with prostate cancer
    Tanaka, Shohei
    Kadoya, Noriyuki
    Ishizawa, Miyu
    Katsuta, Yoshiyuki
    Arai, Kazuhiro
    Takahashi, Haruna
    Xiao, Yushan
    Takahashi, Noriyoshi
    Sato, Kiyokazu
    Takeda, Ken
    Jingu, Keiichi
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2023, 24 (12):
  • [37] Dosimetric Effects of Bladder Preparation and Its Impact on QoL for Ca Prostate SBRT Pts on MR-Linac
    Chiu, S. T.
    Lee, M. C.
    Chan, Y. Y.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S270 - S271
  • [38] Investigating online adaptive workflows for prostate patients on the MR-Linac: an in-silico study
    Jones, S.
    Chuter, R.
    Pollitt, A. J.
    Warren, M.
    McWilliam, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S325 - S325
  • [39] Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac
    Gao, Lin-Rui
    Tian, Yuan
    Wang, Ming-Shuai
    Xia, Wen-Long
    Qin, Shi-Rui
    Song, Yong-Wen
    Wang, Shu-Lian
    Tang, Yu
    Fang, Hui
    Tang, Yuan
    Qi, Shu-Nan
    Yan, Ling-Ling
    Liu, Yue-Ping
    Jing, Hao
    Chen, Bo
    Xing, Nian-Zeng
    Li, Ye-Xiong
    Lu, Ning-Ning
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [40] Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac
    Dang, Jennifer
    Kong, Vickie
    Li, Winnie
    Navarro, Inmaculada
    Winter, Jeff D.
    Malkov, Victor
    Berlin, Alejandro
    Catton, Charles
    Padayachee, Jerusha
    Raman, Srinivas
    Warde, Padraig
    Chung, Peter
    TECHNICAL INNOVATIONS & PATIENT SUPPORT IN RADIATION ONCOLOGY, 2022, 23 : 41 - 46
12345